Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors

Germ Cell Cancer Clinical Trial

Official title:
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors

Status Completed

Clinical Trial Summary

The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects.

Clinical Trial Description

Identification of late-effects through questionnaires and linkage to national registries. DNA samples will be gathered through buccal swabs or saliva kits and analysed with whole exome-sequencing. ;

Study Design

Related Conditions & MeSH terms

Germ Cell Cancer
Neoplasms, Germ Cell and Embryonal

Clinical Trial Details

NCT number	NCT02303015
Study type	Observational
Source	Rigshospitalet, Denmark
Contact
Status	Completed
Phase
Start date	August 2014
Completion date	June 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00996710` - Genomic Structural Variation in Cancer Susceptibility
Active, not recruiting	`NCT01453660` - Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls
Completed	`NCT01242631` - Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer	Phase 2
Completed	`NCT01851200` - Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors	Phase 2
Not yet recruiting	`NCT06275854` - YASU Research Registry: For Young Adults With Cancer
Recruiting	`NCT04897321` - B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)	Phase 1
Not yet recruiting	`NCT06329323` - SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours